Company news
Alfresa Holdings Corporation news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
[Summary]Consolidated Financial Results for the Three Months Ended June 30, 2026(Under Japanese GAAP)
August 5, 2026
Notice on the Decision of Terms of the 1st Issuance of Stock Acquisition Right via Third-Party Allotment for Acquisition of Own Shares via Fully Committed Share Repurchase (Japanese ASR)
May 17, 2026
Notice of the Result and Completion of the Acquisition of Own Shares through Off-Auction Own Share Repurchase Trading System(ToSTNeT-3)
May 17, 2026
Financial Results Summary for the Fiscal Year Ended March 31, 2026
May 15, 2026
Alfresa Holdings: Consolidated Financial Results for the Fiscal Year Ended March 31, 2026(Under Japanese GAAP)
May 15, 2026
Financial Results Summary for the Third Quarter Ended December 31, 2025
February 10, 2026
Signing of an Agreement to Establish a Joint Venture for the Manufacture of Biosimilars
November 25, 2025
neffy® (epinephrine nasal spray) Approved in Japan as the First and Only Needle-Free Emergency Treatment of Allergic Reactions (anaphylaxis)
September 19, 2025